Phosphonic Acid

Phosphonic Acid

SCHEMBL4598729

CCC(CC)(O[Si](C)(C)C)c1ccccc1.O=[PH](O)O

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 2/20 0.33
CHRM2 P08172 2/20 0.33
CHRM1 P11229 2/20 0.33
CHRM3 P20309 2/20 0.33
CYP2C19 P33261 1/20 0.33
HIF1A Q16665 1/20 0.33
ALDH1A1 P00352 1/20 0.32
ALOX15 P16050 1/20 0.32
KIF11 P52732 1/20 0.32
CHRM4 P08173 1/20 0.31
CHRM5 P08912 1/20 0.31
DRD2 P14416 1/20 0.31
OPRM1 P35372 1/20 0.31
DRD3 P35462 1/20 0.31
RIPK1 Q13546 1/20 0.31
CES1 P23141 1/20 0.31
KMT2A Q03164 2/20 0.31
MAPT P10636 1/20 0.31
MEN1 O00255 1/20 0.31
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphonic Acid SCHEMBL11235110 0.84 RIPK1 (0.34) KCNN4ALDH1A1RIPK1KMT2AMAPT
SCHEMBL996408 0.80 MAPK1 (0.40) KCNN4CHRM2CHRM1CHRM3CYP2C19
Phosphonic Acid SCHEMBL29035527 0.72 CHRM2 (0.46) CHRM2CHRM1CHRM3CYP2C19HIF1A
SCHEMBL996208 0.71 CYP2C9 (0.42) ALDH1A1KIF11MAPTLMNAHTT
SCHEMBL7180018 0.71 KCNN4 (0.38) KCNN4CHRM2CHRM1CHRM3CYP2C19
SCHEMBL5564098 0.70 ALDH1A1 (0.52) KCNN4CHRM2CHRM1CHRM3CYP2C19
SCHEMBL1525955 0.70 CA1 (0.36) ALDH1A1KIF11RIPK1KMT2AMEN1
SCHEMBL11207278 0.69 MAPK1 (0.48) KCNN4CHRM2CHRM1CHRM3CYP2C19
SCHEMBL27278714 0.69 KCNN4 (0.43) KCNN4CHRM2CHRM1CHRM3CYP2C19
SCHEMBL2452793 0.69 MAPK1 (0.40) KCNN4CHRM2CHRM1CHRM3CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910309-A2 CYCLOALKYL AMINO-HYDANTOIN COMPOUNDS AND USE THEREOF FOR ß-SECRETASE MODULATION Wyeth (US) 2008-04-16 EP disclosed
WO-2007016012-A2 CYCLOALKYL AMINO-HYDANTOIN COMPOUNDS AND USE THEREOF FOR β-SECRETASE MODULATION WYETH (US) 2007-02-08 WO disclosed
US-20070027199-A1 Cycloalkyl amino-hydantoin compounds and use thereof for beta-secretase modulation WYETH (US) 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027199-A1 Cycloalkyl amino-hydantoin compounds and use thereof for beta-secretase modulation BACE1, BACE2, APP KCNN4 3350/4885CHRM2 2458/4885CHRM1 2695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.